ฝัง
- เผยแพร่เมื่อ 30 พ.ย. 2024
- Discover more about PDE4 inhibitors and patient-centered care strategies: bit.ly/4fHE47p
Psoriasis, a chronic immune-mediated inflammatory skin disorder, significantly impacts patients' quality of life. In this activity, Dr. Steven R. Feldman, Professor of Dermatology at Wake Forest University School of Medicine, and Sara Richardson, a plaque psoriasis patient, explore the latest developments in treating plaque psoriasis, the most common subtype characterized by erythematous plaques and scaling.
Key insights include: - How Phosphodiesterase-4 (PDE4) inhibitors target the inflammatory cascade
The efficacy and safety of PDE4 inhibitors in clinical trials
Patient education strategies to address safety concerns and promote adherence
Perspectives on how PDE4 inhibitors improve quality of life for plaque psoriasis patients
Learn how interdisciplinary care teams can foster communication, enhance therapy adherence, and provide innovative care for plaque psoriasis patients.
#PsoriasisTreatment #PlaquePsoriasis #PDE4Inhibitors #ChronicSkinDisorder #PatientCare #Dermatology #PsoriasisSupport #InnovativeTherapies #HealthcareEducation #StevenFeldman
